Nammi Srinivas, Gudavalli Rambabu, Babu Behara S Ravindra, Lodagala Durga S, Boini Krishna M
Pharmacology Division, Department of Pharmaceutical Sciences, Andhra University, Visakhapatnam-530 003, Andhra Pradesh, INDIA.
BMC Complement Altern Med. 2003 Oct 16;3:5. doi: 10.1186/1472-6882-3-5.
The bark of Terminalia arjuna L. (Combretaceae) is used in Ayurveda since ancient times for the treatment of cardiac disorders. Previous laboratory investigations have demonstrated the use of the bark in cardiovascular complications. The present study was aimed to find the effect of 70% alcoholic extract of Terminalia arjuna on anaesthetized dog blood pressure and probable site of action.
Six dogs were anaesthetized with intraperitoneal injection of thiopental sodium and the blood pressure of each dog (n = 6) was measured from the left common carotid artery connected to a mercury manometer on kymograph. The femoral vein was cannulated for administration of drug solutions. The extract of T. arjuna (dissolved in propylene glycol) in the dose range of 5 to 15 mg/kg were administered intravenously in a pilot study and the dose (6 mg/kg) which produced appreciable hypotension was selected for further studies.
Intravenous administration of T. arjuna produced dose-dependent hypotension in anaesthetized dogs. The hypotension produced by 6 mg/kg dose of the extract was blocked by propranolol but not by atropine or mepyramine maleate. This indicates that muscarinic or histaminergic mechanisms are not likely to be involved in the hypotension produced by the extract. The blockade by propranolol of the hypotension produced by T. arjuna indicates that the extract might contain active compound(s) possessing adrenergic beta2-receptor agonist action and/or that act directly on the heart muscle.
The results indicated the likely involvement of peripheral mechanism for hypotension produced by the 70% alcoholic extract of Terminalia arjuna and lends support for the claims of its traditional usage in cardiovascular disorders.
诃子(使君子科)的树皮自古以来在阿育吠陀医学中就被用于治疗心脏疾病。先前的实验室研究已证实该树皮在心血管并发症治疗中的应用。本研究旨在探究诃子70%乙醇提取物对麻醉犬血压的影响及其可能的作用部位。
6只犬经腹腔注射硫喷妥钠麻醉,通过连接在记纹鼓上的水银压力计从左颈总动脉测量每只犬(n = 6)的血压。股静脉插管用于给药。在一项初步研究中,以5至15 mg/kg的剂量范围静脉注射诃子提取物(溶解于丙二醇),并选择产生明显低血压的剂量(6 mg/kg)用于进一步研究。
静脉注射诃子提取物可使麻醉犬产生剂量依赖性低血压。6 mg/kg剂量提取物产生的低血压可被普萘洛尔阻断,但不能被阿托品或马来酸氯苯那敏阻断。这表明毒蕈碱能或组胺能机制不太可能参与提取物产生的低血压过程。普萘洛尔对诃子产生的低血压的阻断作用表明,该提取物可能含有具有肾上腺素能β2受体激动剂作用和/或直接作用于心肌的活性化合物。
结果表明诃子70%乙醇提取物产生低血压可能涉及外周机制,这为其在心血管疾病传统应用中的说法提供了支持。